InsightsProcurement & Tenders

In 1950, Deming walked into a boardroom of Japanese executives and drew something on the blackboard that nobody in America believed.

By Uttam Dinodia1 min readView this post on LinkedIn

Seven words. One arrow each.

It became the reason Toyota, Sony, and Fuji conquered global markets - while American industry slept.

The Deming Chain Reaction.

Most executives today still don't understand it.

They think quality costs money.
Deming proved the opposite.

Here's the exact sequence he drew:

1. Improve quality

Fewer defects. Fewer delays. Less rework.

2. Costs go down

Better use of machine-time, materials, and human effort.

3. Productivity improves

More good output from the same inputs.

4. Capture the market

Better quality, lower price. Customers notice.

5. Stay in business

Not this quarter. For decades.

6. Provide more jobs

Prosperity rewards everyone in the chain.

Read it slowly. Something stops executives cold.

Quality comes first. Not cost.

Flip it - and the whole chain collapses.

I've seen this play out in pharmaceutical procurement more times than I can count.

A buyer chases the lowest bid on a critical input.
Savings look great on the spreadsheet.
Then come the batch rejections. Regulatory queries. Expired stock.
Emergency air-freight to cover a stockout.

What looked like 8% savings becomes a 30% loss - plus reputational damage that lingers for years.

Deming saw this 75 years ago.

The companies that survive decades don't chase cheaper inputs.
They chase better processes.

Because quality isn't a department. It's a direction.
And the direction sets the destination.

Ask yourself honestly: Is your business running the chain reaction - or running from it?

♻️ Repost if you think more leaders need to rediscover Deming's 75-year-old truth.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.